These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11124893)

  • 41. Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease.
    Gellhaar S; Sunnemark D; Eriksson H; Olson L; Galter D
    Cell Tissue Res; 2017 Sep; 369(3):445-454. PubMed ID: 28466093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostaglandins and cyclooxygenases in glial cells during brain inflammation.
    Tzeng SF; Hsiao HY; Mak OT
    Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):335-40. PubMed ID: 16101543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease.
    Gearhart DA; Collins MA; Lee JM; Neafsey EJ
    Neurobiol Dis; 2000 Jun; 7(3):201-11. PubMed ID: 10860785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclooxygenases in central nervous system diseases: a special role for cyclooxygenase 2 in neuronal cell death.
    Graham SH; Hickey RW
    Arch Neurol; 2003 Apr; 60(4):628-30. PubMed ID: 12707081
    [No Abstract]   [Full Text] [Related]  

  • 45. Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans.
    Tomimoto H; Akiguchi I; Wakita H; Lin JX; Budka H
    Acta Neuropathol; 2000 Jan; 99(1):26-30. PubMed ID: 10651024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Astrocytes and microglia in the substantia nigra and caudate-putamen in Parkinson's disease.
    Knott C; Wilkin GP; Stern G
    Parkinsonism Relat Disord; 1999 Sep; 5(3):115-22. PubMed ID: 18591130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells.
    Shaftel SS; Olschowka JA; Hurley SD; Moore AH; O'Banion MK
    Brain Res Mol Brain Res; 2003 Nov; 119(2):213-5. PubMed ID: 14625089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebral ischemia and inflammation.
    Iadecola C; Alexander M
    Curr Opin Neurol; 2001 Feb; 14(1):89-94. PubMed ID: 11176223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of the immune system in neurodegenerative disorders.
    McGeer EG; McGeer PL
    Mov Disord; 1997 Nov; 12(6):855-8. PubMed ID: 9399206
    [No Abstract]   [Full Text] [Related]  

  • 50. VEGF serum levels are not associated with Parkinson's disease.
    Infante J; Mateo I; Rodríguez-Rodríguez E; Berciano J; Combarros O
    Eur J Neurol; 2007 Aug; 14(8):e6. PubMed ID: 17661998
    [No Abstract]   [Full Text] [Related]  

  • 51. COX-2 in the neurodegenerative process of Parkinson's disease.
    Teismann P
    Biofactors; 2012; 38(6):395-7. PubMed ID: 22826171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra.
    Saggu H; Cooksey J; Dexter D; Wells FR; Lees A; Jenner P; Marsden CD
    J Neurochem; 1989 Sep; 53(3):692-7. PubMed ID: 2760616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitric oxide and basal ganglia degeneration.
    Rose S; MacKenzie GM; Jenner P
    Adv Neurol; 1999; 80():247-57. PubMed ID: 10410729
    [No Abstract]   [Full Text] [Related]  

  • 54. Brain peroxidase and catalase in Parkinson disease.
    Ambani LM; Van Woert MH; Murphy S
    Arch Neurol; 1975 Feb; 32(2):114-8. PubMed ID: 1122174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathobiology of ischaemic stroke: an integrated view.
    Dirnagl U; Iadecola C; Moskowitz MA
    Trends Neurosci; 1999 Sep; 22(9):391-7. PubMed ID: 10441299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CuZn-superoxide dismutase transgenic mice: no effect on longevity, locomotor activity and 3H-mazindol and 3H-spiperone binding over 19 months.
    Gallagher IM; Jenner P; Glover V; Clow A
    Neurosci Lett; 2000 Aug; 289(3):221-3. PubMed ID: 10961669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Superoxide dismutase expression in Parkinson's disease.
    Poirier J; Dea D; Baccichet A; Thiffault C
    Ann N Y Acad Sci; 1994 Nov; 738():116-20. PubMed ID: 7832421
    [No Abstract]   [Full Text] [Related]  

  • 58. [Glial cells in the striatum: a pathological aspect].
    Tooyama I; Kimura H
    No To Shinkei; 1994 Aug; 46(8):757-64. PubMed ID: 7946632
    [No Abstract]   [Full Text] [Related]  

  • 59. Superoxide dismutase and Parkinson's disease.
    Ceballos I; Lafon M; Javoy-Agid F; Hirsch E; Nicole A; Sinet PM; Agid Y
    Lancet; 1990 Apr; 335(8696):1035-6. PubMed ID: 1970085
    [No Abstract]   [Full Text] [Related]  

  • 60. Nitric oxide, glial cells and neuronal degeneration in parkinsonism.
    Hirsch EC; Hunot S
    Trends Pharmacol Sci; 2000 May; 21(5):163-5. PubMed ID: 10785644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.